For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.
He first came into contact with the stock market and shares during his banking apprenticeship. After completing this in 2000, he gained his first journalistic experience in the editorial department of a financial portal. During his subsequent studies in business administration, he also worked in the area of investor relations.
Since then, he has remained true to the capital markets and is excited to report on every newly discovered interesting story - as well as on long-standing success stories.
Commented by Fabian Lorenz
Commented by Fabian Lorenz on August 29th, 2024 | 07:00 CEST
Up to 200% upside potential! Evotec, Tui, and Almonty Industries shares!
Will Evotec's share price double or fall by 40%? Analyst opinions on the ailing biotech company differ widely. The management offers some encouragement, as insiders have been buying shares of Evotec. Almonty is currently performing strongly. The shares of the tungsten producer are at a yearly high. The half-year figures have been convincing, and analysts see around 200% upside potential. Has the share finally initiated its revaluation? By contrast, experts remain skeptical about Tui. Business is booming, but for how much longer?
Read
Commented by Fabian Lorenz on August 28th, 2024 | 07:30 CEST
Share buyback and buy recommendation! Rheinmetall, Aixtron, Saturn Oil + Gas share
Rheinmetall shares well above EUR 600? At least, that is what analysts believe. However, the share of the armaments group is currently struggling somewhat after reaching an all-time high of over EUR 560. But if Rheinmetall now also conquers space, new record highs should only be a matter of time. Analysts believe Saturn Oil & Gas shares have almost 200% upside potential. The oil company, with a market capitalization of over CAD 500 million, is increasingly becoming a free cash flow monster and now plans to use this for share buybacks. Analysts are also taking a positive view of Aixtron again. The technology company confirmed its forecast at an investor conference. How far can the share rise?
Read
Commented by Fabian Lorenz on August 23rd, 2024 | 07:00 CEST
Share price jump and share buyback! Rheinmetall, Barrick Gold, Globex Mining
When will the consolidation of Rheinmetall shares end? After jumping to a new all-time high last week, the share price has gone into reverse gear this week. News from Germany and Poland is unsettling investors. What do analysts say? In contrast, Barrick Gold is doing well. Following convincing quarterly figures, the share is on the verge of breaking through a long-standing resistance level. Globex Mining is also benefiting from the gold boom. The mining incubator is impressing with a positive news flow. Can the share buyback program boost the share? Experts see an opportunity for outperformance.
Read
Commented by Fabian Lorenz on August 15th, 2024 | 07:15 CEST
Takeover! Records! All-time high! Rheinmetall, Barrick Gold, Prismo Metals, and TUI
Strong figures, a takeover, and a share at an all-time high - Rheinmetall is bursting with strength. How much further can the share go? The gold price is also at an all-time high, and industry heavyweight Barrick has released strong figures. Is this finally the time for gold shares and explorers in particular? One exciting candidate is Prismo Metals. The Canadians are not only drilling for gold but also for copper and silver. The newcomer appears to be ripe for a price surge. The TUI share is still a long way from its all-time high. However, a competitor's operational development and insolvency give hope for rising share prices.
Read
Commented by Fabian Lorenz on August 14th, 2024 | 07:00 CEST
Shock for Siemens Energy share! BYD and Altech Advanced Materials are going full throttle!
Will the Siemens Energy share price halve? JP Morgan shocked the Company's shareholders with this theory at the beginning of the week. The latest figures were convincing. How did the analysts arrive at the target price, and is there any hope of the share price rising? Altech Advanced Materials is also likely to see its share price rise. The Company is working on next-generation battery technology, and the first prototypes have exceeded expectations. With a high level of equity and strong partners such as Fraunhofer, the rest of the year looks promising. BYD is also going full throttle, aiming for a 5% market share in Europe soon to avoid tariffs.
Read
Commented by Fabian Lorenz on August 8th, 2024 | 07:00 CEST
Siemens Energy tops, Evotec shocks, and what is causing the dynaCERT share to explode?
The Evotec share lost more than 35% yesterday. The share was already trading at a multi-year low before this drop. Investors were particularly shocked by the adjustment to the EBITDA forecast. Additionally, the biotech company indicated that it plans to downsize. This year, Siemens Energy has shown how quickly a difficult situation can be resolved. On the verge of bankruptcy at the end of 2023, it is back on track, although not thanks to renewable energies. In contrast, dynaCERT has yet to see its share price explode. A former Daimler manager will take the helm in the coming days and is expected to secure orders in Europe. Additionally, dynaCERT investors are waiting for VERRA certification.
Read
Commented by Fabian Lorenz on August 7th, 2024 | 08:05 CEST
Hydrogen sector receives EU billions: Nel, Plug Power, First Hydrogen share!
Governments love green hydrogen. The EU alone plans to spend over EUR 40 billion by 2030 to decarbonize the energy sector. This includes making steel production, heating operations, and combustion engines CO₂-neutral. Additionally, hydrogen can be used to store surplus renewable energy from solar and wind sources. When the Federal Audit Office recently criticized the slow expansion, the EU reaffirmed its targets. Therefore, the pace of expansion should be stepped up, and companies such as Nel and Plug Power - where tomorrow will be exciting - and First Hydrogen want to benefit from this. While the two heavyweights from Norway and the US are unable to get their losses under control and are still highly valued, the newcomer First Hydrogen may be entering the market at just the right time.
Read
Commented by Fabian Lorenz on August 1st, 2024 | 06:30 CEST
Evotec slashed, Bayer sued, and Cardiol Therapeutics share praised
Anyone speculating on a quick rebound for Evotec will be disappointed. At present, one can at most speak of a bottoming out. It is fitting that a renowned analyst has slashed his price target for the German biotech share. Or is it only half as bad? Analysts see massive upside potential for the shares of Cardiol Therapeutics. The share price has more than doubled in the current year and is currently consolidating. There is an exciting entry opportunity now that positive study results have fizzled out on the stock market. Bayer, on the other hand, simply cannot get out of the world's courtrooms. In the US, a new lawsuit has been filed against the Leverkusen-based company; in another case, a multi-million dollar payment must be made.
Read
Commented by Fabian Lorenz on July 31st, 2024 | 06:45 CEST
Nel, Bitcoin Group, VCI Global with Super Micro Computer: Shares on the verge of a mega rally?
The Nel share is driving not only investors to despair but also analysts. While some see 100% upside potential, others are advising investors to sell. And what is the Bitcoin Group doing? After tripling in value, the crypto exchange's share price has corrected significantly in recent weeks. Will the operating figures bring new momentum? VCI Global aims to benefit even more from the boom in artificial intelligence. To meet the demand for computing power, the Company, listed on the NASDAQ and in Frankfurt, plans to set up an AI data centre in Malaysia by mid-2025. Among its partners is the AI heavyweight Super Micro Computer, with chips likely to come from NVIDIA.
Read
Commented by Fabian Lorenz on July 24th, 2024 | 06:30 CEST
BioNTech, Bayer, Vidac Pharma: Buy recommendations and potential worth billions
Can BioNTech shares stop the downward trend? A "Buy" recommendation gives hope. According to this recommendation, the shares of the German biotech flagship have the potential to double in value. Analysts believe a multiplication is possible for Vidac Pharma. The biotech company is pursuing a revolutionary approach in the fight against cancer, and the first drug has a revenue potential of over EUR 1 billion. Even though research is still ongoing, Vidac is not expensive with a market capitalization of less than EUR 10 million, and is a takeover candidate if the study data remain positive. Analysts do not currently see any impetus for an increase in Bayer's share price. However, shareholders should be ready for news from the pharmaceutical pipeline in the coming weeks. These are important for the DAX-listed company.
Read